Evidence map›Paper›PMID 39943236›Full record

ArticleSensors (Basel, Switzerland)2025

Advanced Deep Learning Models for Melanoma Diagnosis in Computer-Aided Skin Cancer Detection.

Ranpreet Kaur, Hamid GholamHosseini, Maria Lindén

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ranpreet KaurDepartment of Software Engineering & AI, Media Design School, Auckland 1010, New Zealand.ORCID 0000-0003-0741-2377
Hamid GholamHosseiniSchool of Engineering, Computer, and Mathematical Sciences, Auckland University of Technology, Auckland 1010, New Zealand.ORCID 0000-0002-0135-2687
Maria LindénDivision of Intelligent Future Technologies, Mälardalen University, 721 23 Västerås, Sweden.ORCID 0000-0003-1940-1747

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most deadly type of skin cancer is melanoma. A visual examination does not provide an accurate diagnosis of melanoma during its early to middle stages. Therefore, an automated model could be developed that assists with early skin cancer detection. It is possible to limit the severity of melanoma by detecting it early and treating it promptly. This study aims to develop efficient approaches for various phases of melanoma computer-aided diagnosis (CAD), such as preprocessing, segmentation, and classification. The first step of the CAD pipeline includes the proposed hybrid method, which uses morphological operations and context aggregation-based deep neural networks to remove hairlines and improve poor contrast in dermoscopic skin cancer images. An image segmentation network based on deep learning is then used to extract lesion regions for detailed analysis and calculate the optimized classification features. Lastly, a deep neural network is used to distinguish melanoma from benign lesions. The proposed approaches use a benchmark dataset named International Skin Imaging Collaboration (ISIC) 2020. In this work, two forms of evaluations are performed with the classification model. The first experiment involves the incorporation of the results from the preprocessing and segmentation stages into the classification model. The second experiment involves the evaluation of the classifier without employing these stages i.e., using raw images. From the study results, it can be concluded that a classification model using segmented and cleaned images contributes more to achieving an accurate classification rate of 93.40% with a 1.3 s test time on a single image.

Indexed as

Deep LearningDiagnosis, Computer-AssistedMelanomaSkin NeoplasmsAlgorithmsDermoscopyHumansImage Processing, Computer-AssistedNeural Networks, Computerclassificationdeep learningmelanomasegmentationskin cancer

Identifiers

PMID39943236
PMCPMC11821218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.